简介：Bridging Wednesdays lunch and evening sessions， Drs. Catherine Stedman and Ed Gane discussed the‘state of play’for direct acting antiviral medication in the most prevalent genotypes(GT)， namely 1， 2， and 3. In a review of trials testing the newest DAAs in different scenarios and combinations， both physicians illustrated the potential and limits of these latest therapies.